Last reviewed · How we verify
autologous dendritic cells with no mRNA transfection
autologous dendritic cells with no mRNA transfection is a Biologic drug developed by Massachusetts General Hospital. It is currently in Phase 1 development. Also known as: Autologous dendritic cells not transfected with mRNA..
At a glance
| Generic name | autologous dendritic cells with no mRNA transfection |
|---|---|
| Also known as | Autologous dendritic cells not transfected with mRNA. |
| Sponsor | Massachusetts General Hospital |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Pilot Study of a Dendritic Cell Vaccine in HIV-1 Infected Subjects (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- autologous dendritic cells with no mRNA transfection CI brief — competitive landscape report
- autologous dendritic cells with no mRNA transfection updates RSS · CI watch RSS
- Massachusetts General Hospital portfolio CI
Frequently asked questions about autologous dendritic cells with no mRNA transfection
What is autologous dendritic cells with no mRNA transfection?
autologous dendritic cells with no mRNA transfection is a Biologic drug developed by Massachusetts General Hospital.
Who makes autologous dendritic cells with no mRNA transfection?
autologous dendritic cells with no mRNA transfection is developed by Massachusetts General Hospital (see full Massachusetts General Hospital pipeline at /company/massachusetts-general-hospital).
Is autologous dendritic cells with no mRNA transfection also known as anything else?
autologous dendritic cells with no mRNA transfection is also known as Autologous dendritic cells not transfected with mRNA..
What development phase is autologous dendritic cells with no mRNA transfection in?
autologous dendritic cells with no mRNA transfection is in Phase 1.
Related
- Manufacturer: Massachusetts General Hospital — full pipeline
- Also known as: Autologous dendritic cells not transfected with mRNA.
- Compare: autologous dendritic cells with no mRNA transfection vs similar drugs
- Pricing: autologous dendritic cells with no mRNA transfection cost, discount & access